Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2003 1
2004 2
2006 2
2007 1
2008 3
2009 3
2010 2
2011 4
2013 4
2014 1
2015 2
2016 2
2017 2
2018 3
2019 3
2020 8
2021 5
2022 6
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies.
Garcia-Prieto CA, Villanueva L, Bueno-Costa A, Davalos V, González-Navarro EA, Juan M, Urbano-Ispizua Á, Delgado J, Ortiz-Maldonado V, Del Bufalo F, Locatelli F, Quintarelli C, Sinibaldi M, Soler M, Castro de Moura M, Ferrer G, Urdinguio RG, Fernandez AF, Fraga MF, Bar D, Meir A, Itzhaki O, Besser MJ, Avigdor A, Jacoby E, Esteller M. Garcia-Prieto CA, et al. Among authors: itzhaki o. J Natl Cancer Inst. 2022 Mar 8;114(3):436-445. doi: 10.1093/jnci/djab194. J Natl Cancer Inst. 2022. PMID: 34581788 Free PMC article.
Adoptive Cell Therapy for Metastatic Melanoma.
Merhavi-Shoham E, Itzhaki O, Markel G, Schachter J, Besser MJ. Merhavi-Shoham E, et al. Among authors: itzhaki o. Cancer J. 2017 Jan/Feb;23(1):48-53. doi: 10.1097/PPO.0000000000000240. Cancer J. 2017. PMID: 28114254 Review.
Adoptive T-cell transfer in melanoma.
Itzhaki O, Levy D, Zikich D, Treves AJ, Markel G, Schachter J, Besser MJ. Itzhaki O, et al. Immunotherapy. 2013 Jan;5(1):79-90. doi: 10.2217/imt.12.143. Immunotherapy. 2013. PMID: 23256800 Review.
The tumor microenvironment: part 1.
Leibovici J, Itzhaki O, Huszar M, Sinai J. Leibovici J, et al. Among authors: itzhaki o. Immunotherapy. 2011 Nov;3(11):1367-84. doi: 10.2217/imt.11.111. Immunotherapy. 2011. PMID: 22053887 Review.
MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2.
Markovits E, Harush O, Baruch EN, Shulman ED, Debby A, Itzhaki O, Anafi L, Danilevsky A, Shomron N, Ben-Betzalel G, Asher N, Shapira-Frommer R, Schachter J, Barshack I, Geiger T, Elkon R, Besser MJ, Markel G. Markovits E, et al. Among authors: itzhaki o. Cancer Immunol Res. 2023 Jul 5;11(7):909-924. doi: 10.1158/2326-6066.CIR-22-0184. Cancer Immunol Res. 2023. PMID: 37074069
53 results